Formula CP

A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic Acid (Formula CP) is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. [PubChem]

Potassium (Formula CP) is the major cation (positive ion) inside animal cells, while sodium is the major cation outside animal cells. The concentration differences of these charged particles causes a difference in electric potential between the inside and outside of cells, known as the membrane potential. The balance between Potassium (Formula CP) and sodium is maintained by ion pumps in the cell membrane. The cell membrane potential created by Potassium (Formula CP) and sodium ions allows the cell generate an action potential—a "spike" of electrical discharge. The ability of cells to produce electrical discharge is critical for body functions such as neurotransmission, muscle contraction, and heart function. Potassium (Formula CP) is also an essential mineral needed to regulate water balance, blood pressure and levels of acidity.

Each capsule contains Co-enzyme Q10 25 mg and 50 mg, respectively.

Ubidecarenone (Formula CP) also contains fractionated coconut oil as an inactive ingredient.

Vitamin B12 (Formula CP) (commonly known as Vitamin B12 (Formula CP)) is the most chemically complex of all the vitamins. Vitamin B12 (Formula CP)'s structure is based on a corrin ring, which, although similar to the porphyrin ring found in heme, chlorophyll, and cytochrome, has two of the pyrrole rings directly bonded. The central metal ion is Co (cobalt). Vitamin B12 (Formula CP) cannot be made by plants or by animals, as the only type of organisms that have the enzymes required for the synthesis of cyanocobalamin are bacteria and archaea. Higher plants do not concentrate cyanocobalamin from the soil and so are a poor source of the substance as compared with animal tissues. Vitamin B12 (Formula CP) is naturally found in foods including meat (especially liver and shellfish), eggs, and milk products.

Vitamin B3 (Formula CP) Lotion: Helps to reduce the appearance of blemishes on larger areas (back and upper chest). It absorbs easily to the skin and does not bleach clothes. Non-photosensitizing, fragrance-free and paraben-free.

Vitamin B3 (Formula CP) Isocorrexion Hydrating Cream: Specially formulated for acne prone skin. Nicotinamide and Anti-Bacterial Adhesive substance (ABA's) helps to clear blemishes. Biophytosebum provides a moisturizing effect, reducing dryness and skin tightness caused by conventional acne treatment.

Vitamin B3 (Formula CP) Oil-Free Cream: An oil-free formula enriched with mattifying agents. It helps to clear blemishes by promoting oil-free skin.

Vitamin B3 (Formula CP) UV High Protection Cream SPF 45: Protects acne-prone skin from daily sun-induced irritation and damage, keeping the skin hydrated and blemish-free at the same time. Non-sensitizing, non-comodogenic, fragrance-free and paraben-free.

Vitamin B3 (Formula CP) Gel: Provides intensive anti-blemish skin care for localized spots and promotes disappearance on the face or other small areas. It is non-sensitizing, fragrance-free and paraben-free.

Vitamin B3 (Formula CP) Moussant Soap Free Cleansing Gel: Helps clear blemishes by purifying and cleansing the skin gently.

A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, Vitamin C (Formula CP), functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C (Formula CP) is considered an antioxidant.

A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Vitamin E (Formula CP)&

Zinc (Formula CP) Capsule: Each capsule contains Zinc (Formula CP) sulphate monohydrate 54.93 mg, thiamine nitrate 10 mg, riboflavin 10 mg, pyridoxine hydrochloride 3 mg, Zinc (Formula CP) (coated) equivalent to cyanocobalamin 15 mcg, ascorbic acid 150 mg, Zinc (Formula CP) 1 mg, nicotinamide 50 mg and calcium pantothenate 12.5 mg.

Zinc (Formula CP) Syrup: Each 5 mL contains Zinc (Formula CP) gluconate 34.9 mg, thiamine mononitrate 2.5 mg, riboflavin 2.5 mg, pyridoxine hydrochloride 1 mg, cyanocobalamin 3 mcg, ascorbic acid 50 mg, d-panthenol 12.5 mg and niacinamide 25 mg in a flavoured liquid glucose sorbitol syrup base.

Vit & mineral deficiencies during recovery, pregnancy, breastfeeding & elderly.

Folic Acid (Formula CP) is used in the treatment and prevention of the folate deficiency state. It does not correct folate deficiency due to dihydrofolate reductase inhibitors. Folic Acid (Formula CP) is also used in women of child-bearing potential and pregnant women to protect against neural tube defects in their offspring. It is also used for the treatment of folate-deficient megaloblastic anaemia, chronic haemolytic states such as thalassaemia major or sickle-cell anaemia.

Magnesium (Formula CP) Sulfate Injection, USP is suitable for replacement therapy in Magnesium (Formula CP) deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. In such cases, the serum Magnesium (Formula CP) (Mg++) level is usually below the lower limit of normal (1.5 to 2.5 mEq/liter) and the serum calcium (Ca++) level is normal (4.3 to 5.3 mEq/liter) or elevated.

In total parenteral nutrition (TPN), Magnesium (Formula CP) sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy.

Magnesium (Formula CP) Sulfate Injection, USP is also indicated for the prevention and control of seizures (convulsions) in pre-eclampsia and eclampsia, respectively.

1. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia.

2. For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, eg, digitalized patients or patients with significant cardiac arrhythmias.

The use of Potassium (Formula CP) salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used. Serum Potassium (Formula CP) should be checked periodically, however, and if hypokalemia occurs, dietary supplementation with Potassium (Formula CP)-containing foods may be adequate to control milder cases. In more severe cases, and if dose adjustment of the diuretic is ineffective or unwarranted, supplementation with Potassium (Formula CP) salts may be indicated.

Oral

Selenium (Formula CP) deficiency

Adult: 100-500 mcg of Selenium (Formula CP) daily.

Intramuscular

Selenium (Formula CP) deficiency

Adult: 100-500 mcg of Selenium (Formula CP) daily.

Intravenous

Selenium (Formula CP) deficiency

Adult: 100-500 mcg of Selenium (Formula CP) daily.

R & D - Ubidecarenone (Formula CP) (Origin) is used as a heart energizer and antioxidant to fight against free radicals in the body. It serves as an energy booster for patients suffering from high-cholesterol, hypertension, congestive heart failure (CHF), and other heart related problems.

Pernicious anemia, both uncomplicated and accompanied by nervous system involvement.

Dietary deficiency of Vitamin B12 (Formula CP), occurring in strict vegetarians and in their breast-fed infants. (Isolated Vitamin B12 (Formula CP) deficiency is very rare).

Malabsorption of Vitamin B12 (Formula CP), resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates Vitamin B12 (Formula CP) absorption. These conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). Folate deficiency in these patients is usually more severe than Vitamin B12 (Formula CP) deficiency.

Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). Total gastrectomy always produces Vitamin B12 (Formula CP) deficiency.

Structural lesions leading to Vitamin B12 (Formula CP) deficiency include regional ileitis, ileal resections, malignancies, etc.

Competition for Vitamin B12 (Formula CP) by intestinal parasites or bacteria.

The fish tapeworm (Diphyilobothrium latum) absorbs huge quantities of Vitamin B12 (Formula CP) and infested patients often have associated gastric atrophy. The blind-loop syndrome may produce deficiency of Vitamin B12 (Formula CP) or folate.

Inadequate utilization of Vitamin B12 (Formula CP). This may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia.

For the Schilling Test.

Helps clear blemishes. Vitamin B3 (Formula CP) Moussant Soap-Free Cleansing Gel Purifies & cleanses the skin. Vitamin B3 (Formula CP) Oil-Free Cream Promotes oil-free skin. Vitamin B3 (Formula CP) Isocorrexion Use for acne prone skin. Reduces skin dryness & tightness caused by conventional acne treatment. Vitamin B3 (Formula CP) Lotion For body acne in chest & back. Vitamin B3 (Formula CP) UV High Protection Cream SPF 45 For sun protection for acne prone skin. Vitamin B3 (Formula CP) Gel For localized spots.

For systemic use of All Natural Source Juicy Orange Vitamin C (Formula CP): prevention and treatment of hypo- and avitaminosis of Vitamin C (Formula CP); providing increased need for Vitamin C (Formula CP) during growth, pregnancy, lactation, with heavy loads, fatigue and during recovery after prolonged severe illness; in winter with an increased risk of infectious diseases.

For intravaginal use: chronic or recurrent vaginitis (bacterial vaginosis, nonspecific vaginitis) caused by the anaerobic flora (due to changes in pH of the vagina) in order to normalize disturbed vaginal microflora.

Oral

Vitamin E (Formula CP) deficiency

Adult: 40-50 mg of d-α tocopherol daily.

Child: Neonate: 10 mg/kg once daily; 1 mth-18 yr: 2-10 mg/kg/day, up to 20 mg/kg.

Oral

Supplementation in cystic fibrosis

Adult: 100-200 mg daily of dl-α-tocoferil acetate or 67-135 mg daily of d-α-tocopherol.

Child: As α- tocopheryl acetate: 1 mth-1 yr 50 mg once daily; 1-12 yr 100 mg once daily; 12-18 yr 200 mg once daily. Dose to be adjusted as needed.

Oral

Abetalipoproteinaemia

Adult: 50-100 mg/kg daily of dl-α-tocoferil acetate or about 33-67 mg/kg daily of d-α-tocopherol.

Child: Neonate: 100 mg/kg once daily; 1 mth-18 yr: 50-100 mg/kg once daily.

Patients with deficiency of B-complex vitamins, Zinc (Formula CP) and Zinc (Formula CP) or where supplementation of these vitamins and Zinc (Formula CP) can be beneficial. Such patients and conditions include: Patients who are on prolonged antibiotic therapy; those who are suffering from infection, injuries, burns, fever, illness; patients with diarrhoea and GI disorders; patients who have undergone surgical operations; patients on diet restrictions eg, in diabetes, anorexia and alcoholism and in elderly persons; pregnant and lactating women due to increased nutritional needs.

Treating vitamin A deficiency. It may also be used for other conditions as determined by your doctor.

Beta-Carotene (Formula CP) is a precursor to vitamin A, a fat-soluble vitamin.

• Beta-Carotene (Formula CP) may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Beta-Carotene (Formula CP). Use a sunscreen or protective clothing if you must be outside for a prolonged period.
• Your skin may turn slightly yellow while you are taking Beta-Carotene (Formula CP). This is harmless and not a cause for concern.
• Do not take large doses of vitamins (megadoses or megavitamin therapy) while taking Beta-Carotene (Formula CP) unless directed by your doctor.
• PREGNANCY and BREAST-FEEDING: If you plan on becoming pregnant, discuss with your doctor the benefits and risks of using Beta-Carotene (Formula CP) during pregnancy. If you are or will be breast feeding while you are using Beta-Carotene (Formula CP), check with your doctor or pharmacist to discuss the risks to your baby.

Vitamins are compounds that you must have for growth and health. They are needed in small amounts only and are usually available in the foods that you eat. Folic Acid (Formula CP) (vitamin B 9) is necessary for strong blood.

Lack of Folic Acid (Formula CP) may lead to anemia (weak blood). Your health care professional may treat this by prescribing Folic Acid (Formula CP) for you.

Some conditions may increase your need for Folic Acid (Formula CP). These include:

• Alcoholism
• Anemia, hemolytic
• Diarrhea (continuing)
• Fever (prolonged)
• Hemodialysis
• Illness (prolonged)
• Intestinal diseases
• Liver disease
• Stress (continuing)
• Surgical removal of stomach

In addition, infants smaller than normal, breast-fed infants, or those receiving unfortified formulas (such as evaporated milk or goat's milk) may need additional Folic Acid (Formula CP).

Increased need for Folic Acid (Formula CP) should be determined by your health care professional.

Some studies have found that Folic Acid (Formula CP) taken by women before they become pregnant and during early pregnancy may reduce the chances of certain birth defects (neural tube defects).

Claims that Folic Acid (Formula CP) and other B vitamins are effective for preventing mental problems have not been proven. Many of these treatments involve large and expensive amounts of vitamins.

Injectable Folic Acid (Formula CP) is given by or under the direction of your health care professional. Another form of Folic Acid (Formula CP) is available without a prescription.

Magnesium (Formula CP) is used as a dietary supplement for individuals who are deficient in Magnesium (Formula CP). Although a balanced diet usually supplies all the Magnesium (Formula CP) a person needs, Magnesium (Formula CP) supplements may be needed by patients who have lost Magnesium (Formula CP) because of illness or treatment with certain medicines.

Lack of Magnesium (Formula CP) may lead to irritability, muscle weakness, and irregular heartbeat.

Injectable Magnesium (Formula CP) is given only by or under the supervision of a health care professional. Some oral Magnesium (Formula CP) preparations are available only with a prescription. Others are available without a prescription.

Potassium (Formula CP) is a mineral that is found in many foods and is needed for several functions of your body, especially the beating of your heart.

Potassium (Formula CP) citrate is used to treat a kidney stone condition called renal tubular acidosis.

Potassium (Formula CP) citrate may also be used for other purposes other than those listed in this medication guide.

Selenium (Formula CP) is mineral that is found in soil and occurs naturally in certain foods (such as whole grains, Brazil nuts, sunflower seeds, and seafood). Selenium (Formula CP) is not produced in the body, but it is needed for proper thyroid and immune system function.

Selenium (Formula CP) is used to treat or prevent Selenium (Formula CP) deficiency.

Selenium (Formula CP) has been used in alternative medicine as an aid to treat Hashimoto's thyroiditis (an autoimmune disorder of the thyroid), and to treat high cholesterol.

Not all uses for Selenium (Formula CP) have been approved by the FDA. Selenium (Formula CP) should not be used in place of medication prescribed for you by your doctor.

Selenium (Formula CP) may also be used for purposes not listed in this product guide.

Ubiquinone is a vitamin-like substance that is made naturally in the body. Ubiquinone is also known as Coenzima, Ubidcarenone, Ubidécarénone, and Ubiquinol.

Ubiquinone has been used in alternative medicine as a likely effective aid in treating coenzyme Q-10 deficiency, or reducing the symptoms of mitochondrial disorders (conditions that affect energy-production in the cells of the body).

Ubiquinone is also possibly effective in preventing migraine headaches, lowering blood pressure, preventing a second heart attack, or slowing the progression of early Parkinson's disease. Ubiquinone is also possibly effective in improving symptoms in people with congestive heart failure, nerve problems caused by diabetes, Huntington's disease, muscular dystrophy, or macular degeneration (age-related vision loss).

Ubiquinone has also been used to treat Alzheimer's disease, high cholesterol, or amyotrophic lateral sclerosis (Lou Gehrig's disease). However, research has shown that ubiquinone may not be effective in treating these conditions.

Research also has shown that ubiquinone is not likely to be effective in increasing athletic performance.

Other uses not proven with research have included treating asthma, COPD, cancer, diabetes, certain heart problems, fibromyalgia, hepatitis C, kidney problems, high blood pressure during pregnancy, muscle problems caused by taking "statin" cholesterol medicine, and other conditions.

Ubiquinone is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.

Ubiquinone may also be used for purposes not listed in this product guide.

Cyanocobalamin is a man-made form of Vitamin B12 (Formula CP). Vitamin B12 (Formula CP) is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.

Cyanocobalamin is used to treat Vitamin B12 (Formula CP) deficiency in people with pernicious anemia and other conditions.

Cyanocobalamin may also be used for purposes not listed in this medication guide.

Ascorbic acid (Vitamin C (Formula CP)) occurs naturally in foods such as citrus fruit, tomatoes, potatoes, and leafy vegetables. Vitamin C (Formula CP) is important for bones and connective tissues, muscles, and blood vessels. Vitamin C (Formula CP) also helps the body absorb iron, which is needed for red blood cell production.

Ascorbic acid is used to treat and prevent Vitamin C (Formula CP) deficiency.

Ascorbic acid may also be used for purposes not listed in this medication guide.

Vitamin E (Formula CP) is an antioxidant that occurs naturally in foods such as nuts, seeds, and leafy green vegetables. Vitamin E (Formula CP) is a fat-soluble vitamin important for many processes in the body.

Vitamin E (Formula CP) is used to treat or prevent Vitamin E (Formula CP) deficiency. People with certain diseases may need extra Vitamin E (Formula CP).

Vitamin E (Formula CP) may also be used for purposes not listed in this medication guide.

Zinc (Formula CP) is a naturally occurring mineral. Zinc (Formula CP) is important for growth and for the development and health of body tissues.

Zinc (Formula CP) sulfate is used to treat and to prevent Zinc (Formula CP) deficiency.

Zinc (Formula CP) sulfate may also be used for purposes not listed in this medication guide.

1 caplet daily.

Usual Adult Dose for Megaloblastic Anemia

1 mg orally, intramuscularly, subcutaneously or IV once a day. May continue until clinical symptoms of folate deficiency and the hematological profile have normalized.

Usual Adult Dose for Folic Acid (Formula CP) Deficiency

400 to 800 mcg orally, intramuscularly, subcutaneously or IV once a day.

Women of childbearing age, pregnant, and lactating women: 800 mcg orally, intramuscularly, subcutaneously or IV once a day.

Usual Pediatric Dose for Folic Acid (Formula CP) Deficiency

Infant:

0.1 mg orally, intramuscularly, subcutaneously or IV once a day.

Child:

Less than 4 years: up to 0.3 mg orally, intramuscularly, subcutaneously or IV once a day.

4 years or older: 0.4 mg orally, intramuscularly, subcutaneously or IV once a day.

Usual Pediatric Dose for Vitamin/Mineral Supplementation

Recommended daily allowance (RDA):

Premature neonates: 50 mcg/day (15 mcg/kg/day).

Full-term neonates and infants 1 to 6 months: 25 to 35 mcg/day.

Children:

1 to 3 years: 150 mcg/day.

4 to 8 years: 200 mcg/day.

9 to 13 years: 300 mcg/day.

14 years and older: 400 mcg/day.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Rarely, a dosage of 2 mg/day may be required, particularly in patients with malabsorption, alcoholism, chronic hemolysis, chronic exfoliative skin disease or who are on concomitant anticonvulsant therapy.

Dialysis

Folic Acid (Formula CP) is removed by both hemodialysis and peritoneal dialysis. The amount removed varies with type equipment used.

Because folate may accumulate in patients with end-stage renal disease, side effects may be more likely in this patient who is undergoing dialysis. Once this patient's body stores of folate are replete, three times a week dosing may be just as beneficial as once daily dosing but should portend a lower risk of side effects.

Other Comments

The recommended daily allowance of Folic Acid (Formula CP) for adult males and females ranges from 150 to 200 and 150 to 180 mcg/day, respectively.

There is a potential danger in administering Folic Acid (Formula CP) to patients with undiagnosed anemia, since Folic Acid (Formula CP) may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress.

Severe megaloblastic anemia may require therapy for 4 to 5 weeks. Once stabilized, if dietary intake is inadequate, maintenance therapy can be started.

Usual Adult Dose for Hypomagnesemia

500 to 1000 mg Magnesium (Formula CP) gluconate (27 to 54 mg elemental Magnesium (Formula CP)) orally 3 times a day.

Usual Adult Dose for Dietary Supplement

500 to 1000 mg Magnesium (Formula CP) gluconate (27 to 54 mg elemental Magnesium (Formula CP)) orally once a day.

Usual Pediatric Dose for Hypomagnesemia

10 to 20 mg/kg of elemental Magnesium (Formula CP) per dose orally 4 times a day. Use Magnesium (Formula CP) gluconate oral liquid preparations for more accurate measurement of dose.

Renal Dose Adjustments

Do not use without physician supervision in patients with renal impairment due to increased risk of hypermagnesemia. The use of Magnesium (Formula CP) salts are generally contraindicated in patients with severe renal dysfunction.

Liver Dose Adjustments

Data not available

Dose Adjustments

May increase by 500 to 1,000 mg/day (27 to 54 mg elemental Magnesium (Formula CP)) in order to achieve a normal serum Magnesium (Formula CP) level. Daily doses > 1,000 mg (54 mg elemental Magnesium (Formula CP)) should be given in 2 to 3 divided doses.

Precautions

Because Magnesium (Formula CP) is primarily eliminated by the kidney, there is significant risk of hypermagnesemia in patients with renal dysfunction.

Dialysis

Data not available; however, use of Magnesium (Formula CP) salts is generally contraindicated in renal failure.

Other Comments

Magnesium (Formula CP) supplements are often used with "low normal" serum Magnesium (Formula CP) levels in patients predisposed to hypomagnesemia (e.g., patients on diuretics).

Dosing Instructions

Treatment with extended release Potassium (Formula CP) Citrate should be added to a regimen that limits salt intake (avoidance of foods with high salt content and of added salt at the table) and encourages high fluid intake (urine volume should be at least two liters per day). The objective of treatment with Potassium (Formula CP) Citrate extended-release tablets is to provide Potassium (Formula CP) Citrate in sufficient dosage to restore normal urinary citrate (greater than 320 mg/day and as close to the normal mean of 640 mg/day as possible), and to increase urinary pH to a level of 6 or 7.

Monitor serum electrolytes (sodium, Potassium (Formula CP), chloride and carbon dioxide), serum creatinine and complete blood counts every four months and more frequently in patients with cardiac disease, renal disease or acidosis. Perform electrocardiograms periodically. Treatment should be discontinued if there is hyperkalemia, a significant rise in serum creatinine or a significant fall in blood hemocrit or hemoglobin.

Severe Hypocitraturia

In patients with severe hypocitraturia (urinary citrate < 150 mg/day), therapy should be initiated at a dosage of 60 mEq/day (30 mEq two times/day or 20 mEq three times/day with meals or within 30 minutes after meals or bedtime snack). Twenty-four hour urinary citrate and/or urinary pH measurements should be used to determine the adequacy of the initial dosage and to evaluate the effectiveness of any dosage change. In addition, urinary citrate and/or pH should be measured every four months. Doses of Potassium (Formula CP) Citrate extended-release tablets greater than 100 mEq/day have not been studied and should be avoided.

Mild to Moderate Hypocitraturia

In patients with mild to moderate hypocitraturia (urinary citrate > 150 mg/day) therapy should be initiated at 30 mEq/day (15 mEq two times/day or 10 mEq three times/day with meals or within 30 minutes after meals or bedtime snack). Twenty-four hour urinary citrate and/or urinary pH measurements should be used to determine the adequacy of the initial dosage and to evaluate the effectiveness of any dosage change. Doses of Potassium (Formula CP) Citrate extended-release tablet greater than 100 mEq/day have not been studied and should be avoided.

Selenium (Formula CP) Injection provides 40 mcg Selenium (Formula CP)/mL. For metabolically stable adults receiving TPN, the suggested additive dosage level is 20 to 40 mcg Selenium (Formula CP)/day. For pediatric patients, the suggested additive dosage level is 3 mcg/kg/day.

In adults, Selenium (Formula CP) deficiency states resulting from long-term TPN support, Selenium (Formula CP) as selenomethionine or selenious acid, administered intravenously at 100 mcg/day for a period of 24 and 31 days, respectively, has been reported to reverse deficiency symptoms without toxicity.

Aseptic addition of Selenium (Formula CP) Injection to the TPN solution under laminar flow hood is recommended. Selenium (Formula CP) is physically compatible with the electrolytes and other trace elements usually present in amino-acid/dextrose solution used for TPN. Frequent monitoring of plasma Selenium (Formula CP) levels is suggested as a guideline for subsequent administration. The normal whole blood range for Selenium (Formula CP) is approximately 10 to 37 mcg/100 mL.

Parenteral drug products should be inspected visually for particulate matter and discoloration, whenever solution and container permit.

Oral

Heart failure

Adult: 50-150 mg daily in 2-3 divided doses.

Oral

Angina pectoris

Adult: 150-600 mg daily in divided doses.

Vitamin B12 (Formula CP) Atlantic Laboratories is used as injections SC, IV, IM, intralumbar, and also oral. With anemia associated with Vitamin B12 (Formula CP) deficiency is introduced on 100-200 mcg in 2 days. In anemia with symptoms of funicular myelosis and megalocytic anemia with diseases of the nervous system - 400-500 micrograms in the first 7 days daily, then 1 time every 5-7 days. In the period of remission in the absence of events funicular myelosis maintenance dose - 100 mcg 2 times a month, in the presence of neurological symptoms - at 200-400 mcg 2-4 times a month. In acute post-hemorrhagic anemia and iron anemia by 30-100 mcg 2-3 times a week. When aplastic anemia (especially in children) - 100 micrograms before clinical improvement. When nutritional anemia in infants and preterm - 30 mcg / day during 15 days.

In diseases of the central and peripheral nervous system and neurological diseases with a pain syndrome is administered in increasing doses - 200-500 mcg, with the improvement in the state - 100 mcg / day. The course of treatment with Vitamin B12 (Formula CP) Atlantic Laboratories is 2 weeks. In traumatic lesions of peripheral nervous system - at 200-400 mcg every other day for 40-45 days.

When hepatitis and cirrhosis - 30-60 mcg / day or 100 mg every other day for 25-40 days.

Dystrophy in young children, Down syndrome and cerebral palsy - by 15-30 mcg every other day.

When funicular myelosis, amyotrophic lateral sclerosis can be introduced into the spinal canal at 15-30 mcg, gradually increasing the dose of 200-250 micrograms.

In radiation sickness, diabetic neuropathy, sprue - by 60-100 mcg daily for 20-30 days.

When deficiency of Vitamin B12 (Formula CP) to prevent - IV or IM for 1 mg 1 time a month; for treatment - IV or IM for 1 mg daily for 1-2 weeks, the maintenance dose is 1-2 mg IV or IM from 1 per week, up to 1 per month. Duration of treatment is determined individually.

Vitamin B3 (Formula CP) Lotion: Apply to the areas being treated after cleansing twice a day, AM & PM.

Vitamin B3 (Formula CP) Isocorrexion & Vitamin B3 (Formula CP) Oil-Free Cream: Apply to the face and affected areas (neck, chest and back) after cleansing twice a day, AM & PM. Massage delicately to facilitate absorption.

Vitamin B3 (Formula CP) UV High Protection Cream SPF 45: Reapply every 2-3 hrs.

Vitamin B3 (Formula CP) Gel: Apply small amount of gel on affected areas by massaging gently in AM & PM.

Vitamin B3 (Formula CP) Moussant Soap Free Cleansing Gel: Apply in AM & PM to damp skin, face and affected areas (neck, chest and back) by massaging delicately. Rinse thoroughly and dry gently. May be used in shower.

This medication administered orally, IM, IV, intravaginally.

For the prevention of deficiency conditions All Natural Source Juicy Orange Vitamin C (Formula CP) dose is 25-75 mg / day, for the treatment - 250 mg / day or more in divided doses.

For intravaginal used ascorbic acid drugs in appropriate dosage forms.

Usual Adult Dose for Vitamin E (Formula CP) Deficiency

Treatment: 60 to 75 units orally once daily.

Prevention: 30 units orally once daily.

Usual Adult Dose for Tardive Dyskinesia

600 to 1600 units orally per day.

Usual Adult Dose for Sickle Cell Anemia

450 units orally per day.

Usual Adult Dose for Alzheimer's Disease

1000 units orally twice daily.

Usual Adult Dose for Dietary Supplement

Oral liquid formulation (Vitamin E (Formula CP)): 200 units (10 mL) orally once daily.

Usual Pediatric Dose for Vitamin E (Formula CP) Deficiency

1 unit/kg/day orally of water-miscible Vitamin E (Formula CP).

Usual Pediatric Dose for Retinopathy Prophylaxis

Prevention of retinopathy of prematurity or Bronchopulmonary dysplasia (BPD) secondary to oxygen therapy: 15 to 30 units/kg/day to maintain plasma levels between 1.5 to 2 mcg/mL (may need as high as 100 units/kg/day). Note: AAP considers this use investigational and routine use is not recommended.

Usual Pediatric Dose for Cystic Fibrosis

100 to 400 units/day orally.

Usual Pediatric Dose for Dietary Supplement

Dosing: 1 unit Vitamin E (Formula CP) = 1 mg dl-alpha-tocopherol acetate.

Oral:

Adequate Intake (AI):

1 to less than 6 months: 4 units daily

6 to less than 12 months: 5 units daily

Recommended Daily Allowance (RDA):

1 to 3 years: 6 units daily

4 to 8 years: 7 units daily

9 to 13 years: 11 units daily

13 years and Older: 15 units daily

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Although no longer available in the U.S., Vitamin E (Formula CP) injectable administered intravenously to premature infants may result in a potentially fatal syndrome consisting of thrombocytopenia, hepatomegaly, splenomegaly, ascites, and renal, hepatic, and pulmonary dysfunction.

Oral administration of large doses (200 mg per day) of a hyperosmolar Vitamin E (Formula CP) preparation to low-birthweight infants has been associated with the development of necrotizing enterocolitis.

Dialysis

Data not available

Other Comments

The oral liquid formulation (Vitamin E (Formula CP) [R]) is intended to enhance absorption in patients with conditions associated with malabsorption (e.g., Crohn's disease, ulcerative colitis ) or for patients who have difficulty swallowing capsules.

The oral liquid formulation (Vitamin E (Formula CP) [R]) may be taken directly or mixed with water or other beverage. It must be shaken well prior to each use and refrigerated after opening.

Zinc (Formula CP) 1 mg/mL (Zinc (Formula CP) Chloride Injection, USP) contains 1 mg Zinc (Formula CP)/mL and is administered intravenously only after dilution. The additive should be diluted prior to administration in a volume of fluid not less than 100 mL. For the metabolically stable adult receiving TPN, the suggested intravenous dosage is 2.5 to 4 mg Zinc (Formula CP)/day (2.5 to 4 mL/day). An additional 2 mg Zinc (Formula CP)/day (2 mL/day) is suggested for acute catabolic states. For the stable adult with fluid loss from the small bowel, an additional 12.2 mg Zinc (Formula CP)/liter of small bowel fluid lost (12.2 mL/liter of small bowel fluid lost), or an additional 17.1 mg Zinc (Formula CP)/kg of stool or ileostomy output (17.1 mL/kg of stool or ileostomy output) is recommended. Frequent monitoring of Zinc (Formula CP) blood levels is suggested for patients receiving more than the usual maintenance dosage level of Zinc (Formula CP).

For full term infants and children up to 5 years of age, 100 mcg Zinc (Formula CP)/kg/day

(0.1 mL/kg/day) is recommended. For premature infants (birth weight less than 1500 g) up to 3 kg in body weight, 300 mcg Zinc (Formula CP)/kg/day (0.3 mL/kg/day) is suggested.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

How supplied

Zinc (Formula CP) 1 mg/mL (Zinc (Formula CP) Chloride Injection, USP) is supplied in 10 mL Plastic Vials (List No. 4090).

Store at 20 to 25°C (68 to 77°F).

HOSPIRA, INC., LAKE FOREST, IL 60045 USA. Revised: October, 2004

See also:
What is the most important information I should know about Folic Acid (Formula CP)?

Because it may mask the hematologic abnormalities while neurological damage progresses, Folic Acid (Formula CP) should not be used in the therapy of patients with vitamin B12 deficiency of any cause, unless there is associated folate deficiency. The Folic Acid (Formula CP) content of one tablet a day however, is unlikely to mask pernicious anemia should this condition be present. Also, pregnancy during pernicious anemia is very rare.

See also:
What is the most important information I should know about Magnesium (Formula CP)?

Do NOT use Calcium Carbonate/Magnesium (Formula CP) Carbonate if:

you are allergic to any ingredient in Calcium Carbonate/Magnesium (Formula CP) Carbonate

you have an increased calcium level in your blood

Contact your doctor or health care provider right away if any of these apply to you.

See also:
What is the most important information I should know about Potassium (Formula CP)?

Potassium (Formula CP) supplements are contraindicated in patients with hyperkalemia since a further increase in serum Potassium (Formula CP) concentration in such patients can produce cardiac arrest. Hyperkalemia may complicate any of the following conditions: chronic renal failure, systemic acidosis, such as diabetic acidosis, acute dehydration, extensive tissue breakdown as in severe burns, adrenal insufficiency, or the administration of a Potassium (Formula CP)-sparing diuretic (eg, spironolactone, triamterene, amiloride).

Controlled-release formulations of Potassium (Formula CP) Chloride have produced esophageal ulceration in certain cardiac patients with esophageal compression due to enlarged left atrium. Potassium (Formula CP) supplementation, when indicated in such patients, should be given as a liquid preparation or as an aqueous (water) suspension of Potassium (Formula CP) Chloride.

All solid oral dosage forms of Potassium (Formula CP) Chloride are contraindicated in any patient in whom there is structural, pathological (eg, diabetic gastroparesis), or pharmacologic (use of anticholinergic agents or other agents with anticholinergic properties at sufficient doses to exert anticholinergic effects) cause for arrest or delay in tablet passage through the gastrointestinal tract.

See also:
What is the most important information I should know about Selenium (Formula CP)?

Selenium (Formula CP) Injection should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

See also:
What is the most important information I should know about Ubidecarenone (Formula CP)?

Young children, pregnant or lactating women or those with severe liver or kidney diseases.

See also:
What is the most important information I should know about Vitamin B12 (Formula CP)?

Hypersensitivity to the components of the formula. History of allergy to the cobalamins (Vitamin B12 (Formula CP) and similar substances). Malignant tumors. By stimulating the growth of tissues, the Cobamamide could increase the high rate of cell multiplication. Sensitivity to cobalt. History of allergies to cobalamin (Vitamin B12 (Formula CP) and related substances).

- Malignant tumor: Due to the action of Vitamin B12 (Formula CP) on the growth of tissue cell multiplication rate high, the risk of exacerbation should be taken into account.

- Children under 6 years because of the dosage form

Contraindications for Vitamin B3 (Formula CP) (Vitamin B3 (Formula CP))

Nicotinic acid is contraindicated in patients with a known hypersensitivity to any component of this medication; significant or unexplained hepatic dysfunction; active peptic ulcer disease; or arterial bleeding.

See also:
What is the most important information I should know about Vitamin C (Formula CP)?

AV-block II and III degree, sinoatrial block, SSS, bradycardia (HR < 40 bpm), hypotension (in case of myocardial infarction, systolic blood pressure less than 100 mm Hg), cardiogenic shock, congestive heart failure IIB-III stages, acute heart failure, Prinzmetal's angina, lactation, concomitant use of MAO inhibitors, hypersensitivity to atenolol.

See also:
What is the most important information I should know about Vitamin E (Formula CP)?

Hypersensitivity to Vitamin E (Formula CP) or any component of the formulation

See also:
What is the most important information I should know about Zinc (Formula CP)?

Hypersensitivity to any of the ingredients of Zinc (Formula CP).

Use Beta-Carotene (Formula CP) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Beta-Carotene (Formula CP) with food or milk.
• If you are unable to swallow a capsule, you may open it and mix the contents with orange juice or tomato juice. Drink the mixture immediately.
• Take Beta-Carotene (Formula CP) regularly to receive the most benefit from it. Taking Beta-Carotene (Formula CP) at the same time each day will help you remember to take it.
• If you miss a dose of Beta-Carotene (Formula CP), take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Beta-Carotene (Formula CP).

Use Folic Acid (Formula CP) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Folic Acid (Formula CP) may be administered as an injection by your health care professional.
• If you are using Folic Acid (Formula CP) at home, carefully follow the injection procedures taught to you by your health care provider. If the medicine contains particles, is discolored, or if the vial is cracked or damaged in any way, do not use it.
• Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor, nurse, or pharmacist to explain local regulations for selecting an appropriate container and properly disposing of the container when full.
• If you miss a dose of Folic Acid (Formula CP), use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Folic Acid (Formula CP).

Use Magnesium (Formula CP) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Magnesium (Formula CP) by mouth with food.
• If you miss a dose of Magnesium (Formula CP) and are using it regularly, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Magnesium (Formula CP).

Use Selenium (Formula CP) lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Shake well before each use.
• Remove jewelry before using Selenium (Formula CP) lotion.
• Do not use on broken or inflamed skin or scalp.
• To use Selenium (Formula CP) lotion on the scalp - Massage 1 or 2 teaspoonfuls of the medicine on the wet scalp. Leave on the scalp for 2 to 3 minutes. Rinse scalp thoroughly. Wash hands well after treatment. If you are using Selenium (Formula CP) lotion before or after bleaching, tinting, or permanent waving of hair, rinse hair for at least 5 minutes in cool running water.
• To use Selenium (Formula CP) lotion on the skin - Apply a sufficient amount to cover affected areas of the body. Lather well with a small amount of water. Leave the medicine on the skin for 10 minutes. Rinse thoroughly in the shower. Wash hands well after treatment.
• If you miss a dose of Selenium (Formula CP) lotion, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once

Ask your health care provider any questions you may have about how to use Selenium (Formula CP) lotion.

Folic Acid (Formula CP) is the man-made form of folate. Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells.

Folic Acid (Formula CP) supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of Folic Acid (Formula CP) either through their diet or supplements to prevent infant spinal cord birth defects.

How to use Folic Acid (Formula CP)

Take this product by mouth with or without food as directed by your doctor, usually once daily. If you are taking the over-the-counter product, follow all directions on the product package. If you have any questions, ask your doctor or pharmacist.

Dosage is based on your medical condition and response to treatment. Do not increase your dose or take this product more often than directed.

Take this product regularly to get the most benefit from it. To help you remember, take it at the same time each day. Follow the diet plan recommended by your doctor or dietician. See also Notes section.

If your condition persists or worsens, or if you think you may have a serious medical problem, get medical help right away.

This medication is a mineral supplement used to prevent and treat low amounts of Magnesium (Formula CP) in the blood. Magnesium (Formula CP) is very important for the normal functioning of cells, nerves, muscles, bones, and the heart. Usually, a well-balanced diet provides normal blood levels of Magnesium (Formula CP). However, certain situations cause your body to lose Magnesium (Formula CP) faster than you can replace it from your diet. These situations include treatment with "water pills" (diuretics such as furosemide, hydrochlorothiazide), a poor diet, alcoholism, or other medical conditions (e.g., severe diarrhea/vomiting, stomach/intestinal absorption problems, poorly controlled diabetes).

How to use Magnesium (Formula CP) amino acid chelate

Take this product by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

It is best to take Magnesium (Formula CP) supplements with a meal to reduce stomach upset and diarrhea unless otherwise directed by the product instructions or your doctor.

Take each dose with a full glass (8 ounces or 240 milliliters) of water unless your doctor directs you otherwise. Swallow extended-release capsules and delayed-release/enteric coated tablets or capsules whole. Do not crush or chew extended-release or delayed-release/enteric coated capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

If you are using a liquid product, use a medication measuring device to carefully measure the dose. Do not use a household spoon because you may not get the correct dose. If you are using a suspension, shake the bottle well before each dose.

Take this medication regularly in order to get the most benefit from it. Remember to take it at the same time(s) each day. Dosage is based on your medical condition and response to treatment. Do not increase your dose or take it more often than directed on the product package or by your doctor. Too much Magnesium (Formula CP) in the blood can cause serious side effects.

Tell your doctor if symptoms of low Magnesium (Formula CP) blood levels (e.g., muscle cramps, tiredness, irritability, depression) persist or worsen. If you think you may have a serious medical problem, seek immediate medical attention.

This medication is a mineral supplement used to treat or prevent low amounts of Potassium (Formula CP) in the blood. A normal level of Potassium (Formula CP) in the blood is important. Potassium (Formula CP) helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough Potassium (Formula CP) by eating a well-balanced diet. Some conditions that can lower your body's Potassium (Formula CP) level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.

How to use Potassium (Formula CP)

Take this medication by mouth as directed by your doctor, usually 1 to 4 times daily. To prevent stomach upset, take each dose with a meal. Dissolve the prescribed number of tablets in at least 4 ounces (120 milliliters) of cold water or juice per tablet. After the tablets are fully dissolved, sip the liquid slowly over 5 to 10 minutes. If you have upset stomach, mixing your dose in a larger amount of liquid may help.

Take this medication regularly to get the most benefit from it. To help you remember, take it at the same time(s) each day. The dosage is based on your medical condition and response to treatment. Do not increase your dose or take it more often than prescribed.

Tell your doctor if your condition does not improve or if you have symptoms of low Potassium (Formula CP) in the blood (such as irregular heartbeat, muscle weakness/cramps).

Selenium (Formula CP) is used as a dietary supplement mainly in the treatment of Selenium (Formula CP) deficiency affecting young women and children with Keshan disease. It is also used for treatment of osteoarthiritis associated with poor Selenium (Formula CP) levels in body called Kashin-Beck Disease. Selenium (Formula CP) supplements are also used in patients with HIV/ AIDS to maintain the adequate Selenium (Formula CP) levels.

Coenzyme Q10 has been used for heart problems (e.g., heart failure, angina), high blood pressure, Parkinson's disease, gum disease, and certain diseases passed down through families (Huntington's disease, muscular dystrophy). It has also been used for preventing migraine headaches and for preventing cell damage that may occur after surgery or treatment with certain anti-cancer drugs. If you have or think you have any of the conditions listed above, consult your doctor for advice on proper care and treatment.

Coenzyme Q10 is a substance that your body normally makes. Your body uses it to help keep in good health.

Some herbal/diet supplement products have been found to contain possibly harmful impurities/additives. Check with your pharmacist for more details about the brand you use.

The FDA has not reviewed this product for safety or effectiveness. Consult your doctor or pharmacist for more details.

How to use Ubidecarenone (Formula CP)

This product is taken by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

If you are using a liquid or powder form, carefully measure your dose using a medication-measuring device or spoon. Do not use a household spoon because you may not get the correct dose. If your liquid form is a suspension, shake the bottle well before measuring each dose. If your liquid comes in a tube/ampule, take the dose immediately after opening and discard any left over liquid. Follow the manufacturer's directions for mixing the powder form.

If you are using chewable tablets or wafers, chew each dose thoroughly before swallowing.

If you are using a tablet made to dissolve in the mouth, dry your hands before handling the tablet. Place each dose on the tongue and allow to dissolve completely, then swallow it with saliva or water.

Do not crush or chew extended-release tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split the tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

If your condition persists or worsens, or if you think you may have a serious medical problem, seek immediate medical attention.

Hypercholesterolaemia, hyperlipidemia, hypertriglyceridaemia, pellagra.

Ascorbic acid (Vitamin C (Formula CP)) is used to prevent or treat low levels of Vitamin C (Formula CP) in people who do not get enough of the vitamin from their diets. Most people who eat a normal diet do not need extra ascorbic acid. Low levels of Vitamin C (Formula CP) can result in a condition called scurvy. Scurvy may cause symptoms such as rash, muscle weakness, joint pain, tiredness, or tooth loss.

Vitamin C (Formula CP) plays an important role in the body. It is needed to maintain the health of skin, cartilage, teeth, bone, and blood vessels. It is also used to protect your body's cells from damage. It is known as an antioxidant.

OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.

This vitamin may also be used with other vitamins for a certain eye condition (macular degeneration).

How to use Vitamin C (Formula CP)

Take this vitamin by mouth with or without food, usually 1 to 2 times daily. Follow all directions on the product package, or take as directed by your doctor.

If you are taking the extended-release capsules, swallow them whole. Do not crush or chew extended-release capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing. Take this product with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise.

If you are taking the wafers or chewable tablets, chew them thoroughly and then swallow. If you are taking the lozenges, place the lozenge in your mouth and allow it to slowly dissolve.

If you are taking the powder, mix it thoroughly in the proper amount of liquid and stir well. Drink all of the liquid right away. Do not prepare a supply for future use. If you are using the liquid form of this vitamin, carefully measure the dose using a special measuring device/spoon. Do not use a household spoon because you may not get the correct dose.

Dosage is based on your medical condition and response to treatment.

Use this vitamin regularly to get the most benefit from it. To help you remember, take it at the same time(s) each day.

If you think you may have a serious medical problem, seek immediate medical attention.

This supplement is used to prevent or treat a lack of Vitamin E (Formula CP) in the body. A low body level of Vitamin E (Formula CP) is rare. Most people who eat a normal diet do not need extra Vitamin E (Formula CP). However, Vitamin E (Formula CP) supplements are used in premature newborns and in people who have problems absorbing enough Vitamin E (Formula CP) from their diets. Vitamin E (Formula CP) is important in protecting your body's cells from damage. It is known as an antioxidant.

How to use Natural Vitamin E (Formula CP)

Take this product by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

If you are using a liquid form of this product, carefully measure your dose using a medication-measuring device or spoon. Do not use a household spoon because you may not get the correct dose. If your liquid form is a suspension, shake the bottle well before each dose.

Dosage is based on your medical condition and response to treatment. Do not increase your dose or take it more often than recommended. Taking too much Vitamin E (Formula CP) may increase your risk of side effects.

High doses of Vitamin E (Formula CP) (400 units or more per day) may increase the chance of rare but very serious side effects. There is no proof that high doses of Vitamin E (Formula CP) help to prevent or treat heart disease. There is very little evidence that it helps prevent or treat Alzheimer's disease. In some people, taking these high doses may even be harmful. Talk to your doctor or pharmacist and discuss the risks and benefits before taking Vitamin E (Formula CP) supplements.

If your doctor prescribes this product for Vitamin E (Formula CP) deficiency, use it regularly to get the most benefit from it. To help you remember, take it at the same time each day. You should see improvement of symptoms such as numbness/tingling of the hands/feet and weakness. If your condition persists or worsens, or if you think you may have a serious medical problem, seek immediate medical attention.

Reduce levodopa effects; increase Fe absorption.

See also:
What other drugs will affect Folic Acid (Formula CP)?

Medications that interfere with your bodys ability to use folate may also increase the need for this vitamin. Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and Folic Acid (Formula CP). Folic Acid (Formula CP) supplements can correct the anemia associated with vitamin B12 deficiency. Unfortunately, Folic Acid (Formula CP) will not correct changes in the nervous system that result from vitamin B12 deficiency. Permanent nerve damage could theoretically occur if vitamin B12 deficiency is not treated. Therefore, intake of supplemental Folic Acid (Formula CP) should not exceed 1000 micrograms (g, sometimes mcg) per day to prevent Folic Acid (Formula CP) from masking symptoms of vitamin B12 deficiency. It is important for older adults to be aware of the relationship between Folic Acid (Formula CP) and vitamin B12 because they are at greater risk of having a vitamin B12 deficiency. If you are 50 years of age or older, ask your physician to check your B12 status before you take a supplement that contains Folic Acid (Formula CP).

See also:
What other drugs will affect Magnesium (Formula CP)?

Alfacalcidol: May increase the serum concentration of Magnesium (Formula CP) Salts. Consider therapy modification

Alpha-Lipoic Acid: Magnesium (Formula CP) Salts may decrease the absorption of Alpha-Lipoic Acid. Alpha-Lipoic Acid may decrease the absorption of Magnesium (Formula CP) Salts. Consider therapy modification

Baloxavir Marboxil: Polyvalent Cation Containing Products may decrease the serum concentration of Baloxavir Marboxil. Avoid combination

Bictegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Bictegravir. Management: Administer bictegravir under fasting conditions at least 2 hours before or 6 hours after polyvalent cation containing products. Coadministration of bictegravir with or 2 hours after most polyvalent cation products is not recommended. Consider therapy modification

Bisphosphonate Derivatives: Polyvalent Cation Containing Products may decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral medications containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Pamidronate; Zoledronic Acid. Consider therapy modification

Calcitriol (Systemic): May increase the serum concentration of Magnesium (Formula CP) Salts. Management: Consider using a non-Magnesium (Formula CP)-containing antacid or phosphate-binding product in patients also receiving calcitriol. If Magnesium (Formula CP)-containing products must be used with calcitriol, serum Magnesium (Formula CP) concentrations should be monitored closely. Consider therapy modification

Calcium Channel Blockers: May enhance the adverse/toxic effect of Magnesium (Formula CP) Salts. Magnesium (Formula CP) Salts may enhance the hypotensive effect of Calcium Channel Blockers. Monitor therapy

Deferiprone: Polyvalent Cation Containing Products may decrease the serum concentration of Deferiprone. Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours. Consider therapy modification

Dolutegravir: Magnesium (Formula CP) Salts may decrease the serum concentration of Dolutegravir. Management: Administer dolutegravir at least 2 hours before or 6 hours after oral Magnesium (Formula CP) salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral Magnesium (Formula CP) salts. Consider therapy modification

Doxercalciferol: May enhance the hypermagnesemic effect of Magnesium (Formula CP) Salts. Management: Consider using a non-Magnesium (Formula CP)-containing antacid or phosphate-binding product in patients also receiving doxercalciferol. If Magnesium (Formula CP)-containing products must be used with doxercalciferol, serum Magnesium (Formula CP) concentrations should be monitored closely. Consider therapy modification

Eltrombopag: Polyvalent Cation Containing Products may decrease the serum concentration of Eltrombopag. Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any polyvalent cation containing product. Consider therapy modification

Elvitegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Elvitegravir. Management: Administer elvitegravir 2 hours before or 6 hours after the administration of polyvalent cation containing products. Consider therapy modification

Gabapentin: Magnesium (Formula CP) Salts may enhance the CNS depressant effect of Gabapentin. Specifically, high dose intravenous/epidural Magnesium (Formula CP) sulfate may enhance the CNS depressant effects of gabapentin. Magnesium (Formula CP) Salts may decrease the serum concentration of Gabapentin. Management: Administer gabapentin at least 2 hours after use of a Magnesium (Formula CP)-containing antacid. Monitor patients closely for evidence of reduced response to gabapentin therapy. Monitor for CNS depression if high dose IV/epidural Magnesium (Formula CP) sulfate is used. Consider therapy modification

Levothyroxine: Magnesium (Formula CP) Salts may decrease the serum concentration of Levothyroxine. Management: Separate administration of oral levothyroxine and oral Magnesium (Formula CP) salts by at least 4 hours. Consider therapy modification

Multivitamins/Fluoride (with ADE): Magnesium (Formula CP) Salts may decrease the serum concentration of Multivitamins/Fluoride (with ADE). Specifically, Magnesium (Formula CP) salts may decrease fluoride absorption. Management: To avoid this potential interaction separate the administration of Magnesium (Formula CP) salts from administration of a fluoride-containing product by at least 1 hour. Consider therapy modification

Mycophenolate: Magnesium (Formula CP) Salts may decrease the serum concentration of Mycophenolate. Management: Separate doses of mycophenolate and oral Magnesium (Formula CP) salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral Magnesium (Formula CP) salts. Consider therapy modification

Neuromuscular-Blocking Agents: Magnesium (Formula CP) Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Monitor therapy

PenicillAMINE: Polyvalent Cation Containing Products may decrease the serum concentration of PenicillAMINE. Management: Separate the administration of penicillamine and oral polyvalent cation containing products by at least 1 hour. Consider therapy modification

Phosphate Supplements: Magnesium (Formula CP) Salts may decrease the serum concentration of Phosphate Supplements. Management: Administer oral phosphate supplements as far apart from the administration of an oral Magnesium (Formula CP) salt as possible to minimize the significance of this interaction. Exceptions: Sodium Glycerophosphate Pentahydrate. Consider therapy modification

Quinolones: Magnesium (Formula CP) Salts may decrease the serum concentration of Quinolones. Management: Administer oral quinolones several hours before (4 h for moxi/pe/spar-, 2 h for others) or after (8 h for moxi-, 6 h for cipro/dela-, 4 h for lome/pe-, 3 h for gemi-, and 2 h for levo-, nor-, or ofloxacin or nalidixic acid) oral Magnesium (Formula CP) salts. Exceptions: LevoFLOXacin (Oral Inhalation). Consider therapy modification

Raltegravir: Magnesium (Formula CP) Salts may decrease the serum concentration of Raltegravir. Management: Avoid the use of oral / enteral Magnesium (Formula CP) salts with raltegravir. No dose separation schedule has been established that adequately reduces the magnitude of interaction. Avoid combination

Tetracyclines: Magnesium (Formula CP) Salts may decrease the absorption of Tetracyclines. Only applicable to oral preparations of each agent. Management: Avoid coadministration of oral Magnesium (Formula CP) salts and oral tetracyclines. If coadministration cannot be avoided, administer oral Magnesium (Formula CP) at least 2 hours before, or 4 hours after, oral tetracyclines. Monitor for decreased tetracycline therapeutic effects. Exceptions: Eravacycline. Consider therapy modification

Trientine: Polyvalent Cation Containing Products may decrease the serum concentration of Trientine. Management: Avoid concomitant administration of trientine and oral products that contain polyvalent cations. If oral iron supplements are required, separate the administration by 2 hours. If other oral polyvalent cations are needed, separate administration by 1 hour. Consider therapy modification

See also:
What other drugs will affect Potassium (Formula CP)?

Aliskiren: Potassium (Formula CP) Salts may enhance the hyperkalemic effect of Aliskiren. Monitor therapy

Alpha-/Beta-Agonists (Indirect-Acting): Alkalinizing Agents may increase the serum concentration of Alpha-/Beta-Agonists (Indirect-Acting). Monitor therapy

Aluminum Hydroxide: Citric Acid Derivatives may increase the absorption of Aluminum Hydroxide. Monitor therapy

Amantadine: Alkalinizing Agents may increase the serum concentration of Amantadine. Monitor therapy

Amphetamines: Alkalinizing Agents may decrease the excretion of Amphetamines. Management: Consider alternatives to using amphetamines and alkalinizing agents in combination. If these agents must be used together, patients should be monitored closely for excessive amphetamine effects. Consider therapy modification

Angiotensin II Receptor Blockers: Potassium (Formula CP) Salts may enhance the hyperkalemic effect of Angiotensin II Receptor Blockers. Monitor therapy

Angiotensin-Converting Enzyme Inhibitors: Potassium (Formula CP) Salts may enhance the hyperkalemic effect of Angiotensin-Converting Enzyme Inhibitors. Monitor therapy

Anticholinergic Agents: May enhance the ulcerogenic effect of Potassium (Formula CP) Citrate. Avoid combination

Drospirenone: Potassium (Formula CP) Salts may enhance the hyperkalemic effect of Drospirenone. Monitor therapy

Eplerenone: May enhance the hyperkalemic effect of Potassium (Formula CP) Salts. Management: This combination is contraindicated in patients receiving eplerenone for treatment of hypertension. Consider therapy modification

Heparin: May enhance the hyperkalemic effect of Potassium (Formula CP) Salts. Monitor therapy

Heparins (Low Molecular Weight): May enhance the hyperkalemic effect of Potassium (Formula CP) Salts. Monitor therapy

Mecamylamine: Alkalinizing Agents may increase the serum concentration of Mecamylamine. Monitor therapy

Memantine: Alkalinizing Agents may increase the serum concentration of Memantine. Monitor therapy

Nicorandil: May enhance the hyperkalemic effect of Potassium (Formula CP) Salts. Monitor therapy

Potassium (Formula CP)-Sparing Diuretics: Potassium (Formula CP) Salts may enhance the hyperkalemic effect of Potassium (Formula CP)-Sparing Diuretics. Management: Avoid coadministration of a Potassium (Formula CP)-sparing diuretic and a Potassium (Formula CP) salt. This combination should only be used in cases of significant hypokalemia, and only if serum Potassium (Formula CP) can be closely monitored. Consider therapy modification

QuiNINE: Alkalinizing Agents may increase the serum concentration of QuiNINE. Monitor therapy

See also:
What other drugs will affect Selenium (Formula CP)?

Baloxavir Marboxil: Polyvalent Cation Containing Products may decrease the serum concentration of Baloxavir Marboxil. Avoid combination

Bictegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Bictegravir. Management: Administer bictegravir under fasting conditions at least 2 hours before or 6 hours after polyvalent cation containing products. Coadministration of bictegravir with or 2 hours after most polyvalent cation products is not recommended. Consider therapy modification

Bisphosphonate Derivatives: Polyvalent Cation Containing Products may decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral medications containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Pamidronate; Zoledronic Acid. Consider therapy modification

Deferiprone: Polyvalent Cation Containing Products may decrease the serum concentration of Deferiprone. Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours. Consider therapy modification

Dolutegravir: Selenium (Formula CP) may decrease the serum concentration of Dolutegravir. Management: Administer dolutegravir at least 2 hours before or 6 hours after oral Selenium (Formula CP). Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral Selenium (Formula CP). Consider therapy modification

Eltrombopag: Polyvalent Cation Containing Products may decrease the serum concentration of Eltrombopag. Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any polyvalent cation containing product. Consider therapy modification

Elvitegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Elvitegravir. Management: Administer elvitegravir 2 hours before or 6 hours after the administration of polyvalent cation containing products. Consider therapy modification

PenicillAMINE: Polyvalent Cation Containing Products may decrease the serum concentration of PenicillAMINE. Management: Separate the administration of penicillamine and oral polyvalent cation containing products by at least 1 hour. Consider therapy modification

Raltegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Raltegravir. Management: Administer raltegravir 2 hours before or 6 hours after administration of the polyvalent cations. Dose separation may not adequately minimize the significance of this interaction. Consider therapy modification

Trientine: Polyvalent Cation Containing Products may decrease the serum concentration of Trientine. Management: Avoid concomitant administration of trientine and oral products that contain polyvalent cations. If oral iron supplements are required, separate the administration by 2 hours. If other oral polyvalent cations are needed, separate administration by 1 hour. Consider therapy modification

See also:
What other drugs will affect Ubidecarenone (Formula CP)?

If you are taking this product under your doctor's direction, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.

Before using this product, tell your doctor or pharmacist of all prescription and nonprescription medications you may use, especially of: drugs for high blood pressure, "blood thinners" (e.g., warfarin), drugs for diabetes, drugs for high cholesterol (e.g., atorvastatin, lovastatin).

This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

See also:
What other drugs will affect Vitamin B12 (Formula CP)?

In an application of Vitamin B12 (Formula CP) Atlantic Laboratories with hormonal contraceptives for oral administration may decrease the concentration of cyanocobalamin in plasma.

In an application with anticonvulsant drugs decreased cyanocobalamin absorption from the gut.

In an Vitamin B12 (Formula CP) Atlantic Laboratories application with neomycin, aminosalicylic acid, colchicine, cimetidine, ranitidine, drugs Vitamin B12 (Formula CP) decreased cyanocobalamin absorption from the gut.

Cyanocobalamin may exacerbate allergic reactions caused by thiamine.

When parenteral application of chloramphenicol may decrease the hematopoietic effects of cyanocobalamin with anemia.

Interactions for Vitamin B3 (Formula CP) (Vitamin B3 (Formula CP))

Antihypertensive Therapy: Nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension

Aspirin: Concomitant aspirin may decrease the metabolic clearance of nicotinic acid. The clinical relevance of this finding is unclear

Other: Concomitant alcohol or hot drinks may increase the side effects of flushing and pruritus and should be avoided at the time of drug ingestion.

See also:
What other drugs will affect Vitamin C (Formula CP)?

In an application with barbiturates, primidone increases the excretion of ascorbic acid in the urine.

With the simultaneous use of oral contraceptives reduces the concentration of ascorbic acid in blood plasma.

In an application of All Natural Source Juicy Orange Vitamin C (Formula CP) with iron preparations ascorbic acid, due to its regenerative properties, transforms ferric iron in the bivalent, which improves its absorption.

Ascorbic acid in high doses can decrease urine pH that while the application reduces the tubular reabsorption of amphetamine and tricyclic antidepressants.

With the simultaneous use of aspirin reduces the absorption of ascorbic acid by about a third.

All Natural Source Juicy Orange Vitamin C (Formula CP) in an application with warfarin may decrease effects of warfarin.

With the simultaneous application of ascorbic acid increases the excretion of iron in patients receiving deferoxamine. In the application of ascorbic acid at a dose of 500 mg / day possibly left ventricular dysfunction.

In an application with tetracycline is increased excretion of ascorbic acid in the urine.

There is a described case of reducing the concentration of fluphenazine in plasma in patients treated with ascorbic acid 500 mg 2 times / day.

May increase the concentration of ethinyl estradiol in the blood plasma in its simultaneous application in the oral contraceptives.

See also:
What other drugs will affect Vitamin E (Formula CP)?

Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): Vitamin E (Formula CP) (Systemic) may enhance the antiplatelet effect of Agents with Antiplatelet Properties. Monitor therapy

Anticoagulants: Vitamin E (Formula CP) (Systemic) may enhance the anticoagulant effect of Anticoagulants. Monitor therapy

CycloSPORINE (Systemic): Vitamin E (Formula CP) (Systemic) may decrease the serum concentration of CycloSPORINE (Systemic). Monitor therapy

Ibrutinib: Vitamin E (Formula CP) (Systemic) may enhance the antiplatelet effect of Ibrutinib. Monitor therapy

Orlistat: May decrease the serum concentration of Vitamins (Fat Soluble). Management: Administer oral fat soluble vitamins at least 2 hours before or after the administration of orlistat. Similar precautions do not apply to parenterally administered fat soluble vitamins. Consider therapy modification

Tipranavir: May enhance the adverse/toxic effect of Vitamin E (Formula CP) (Systemic). Management: Patients taking tipranavir oral solution are advised to avoid taking additional Vitamin E (Formula CP), beyond the amounts contained in a multivitamin product. This interaction does not apply to tipranavir capsules. Consider therapy modification

See also:
What other drugs will affect Zinc (Formula CP)?

Pyridoxine reduces the effects of levodopa (but this does not occur if a dopa decarboxylase is also given); decreases serum concentrations of phenobarbitone. Concurrent administration of drugs eg, isoniazid, penicillamine and oral contraceptives increase the requirement for pyridoxine.

Absorption of cyanocobalamin from the GIT may be reduced by neomycin, aminosalicylic acid, histamine H₂-receptor antagonists and colchicine. Serum concentrations may be decreased by concurrent administration of oral contraceptives. Many of these interactions are unlikely to be of clinical significance but should be taken into account when performing assays for blood concentrations.

Parenteral chloramphenicol may attenuate the effect of Zinc (Formula CP) in anaemia.

Folate deficiency states may be produced by a number of drugs including antiepileptics, oral contraceptives, antituberculous drugs, alcohol and Zinc (Formula CP) antagonists eg, aminopterin, methotrexate, pyrimethamine, trimethoprim and sulphonamides; Zinc (Formula CP) may decrease serum-phenytoin concentrations.

There may be an increased risk of myopathy or rhabdomyolysis when nicotinic acid is used concurrently with statins. Nicotinamide may increase the requirements for insulin or oral hypoglycaemics.

Ascorbic acid may increase the absorption of iron-deficiency states.

Ascorbic acid is often given in addition to desferrioxamine to patients with iron overload (thalassemia) to achieve better iron excretion. However, early on in treatment when there is excess tissue iron, there is some evidence that ascorbic acid may worsen the iron toxicity, particularly to the heart. Thus, ascorbic acid should not be given for the first month after starting desferrioxamine treatment.

The absorption of Zinc (Formula CP) may be reduced by iron supplements, penicillamine, phosphorus-containing preparations and tetracyclines. Zinc (Formula CP) supplements reduce the absorption of copper, ciprofloxacin, iron, norfloxacin, penicillamine and tetracyclines.

See also:
What are the possible side effects of Beta-Carotene (Formula CP)?

Beta-Carotene (Formula CP) is generally well tolerated with a very low risk of toxicity. In contrast with vitamin A (excess intake of which may cause liver damage or birth defects), it is virtually impossible to overdose with Beta-Carotene (Formula CP), as the body eliminates any of the latter substance which is surplus to requirements. No adverse effects have been reported in pregnant or lactating women taking up to 50,000IU/day, and intakes up to 1000mg/Kg body weight given to rats showed no long term toxic effects. Very high intake of Beta-Carotene (Formula CP) (more than 100,000IU/day) may cause areas of the skin to take on an orange tone, which is harmless. Patients with diabetes, renal or liver disease, or with hyperthyroidism should take Beta-Carotene (Formula CP) with caution.

See also:
What are the possible side effects of Folic Acid (Formula CP)?

Allergic sensitization has been reported following both oral and parenteral administration of Folic Acid (Formula CP).

Folic Acid (Formula CP) is relatively nontoxic in man. Rare instances of allergic responses to Folic Acid (Formula CP) preparations have been reported and have included erythema, skin rash, itching, general malaise, and respiratory difficulty due to bronchospasm. One patient experienced symptoms suggesting anaphylaxis following injection of the drug. Gastrointestinal side effects, including anorexia, nausea, abdominal distention, flatulence, and a bitter or bad taste, have been reported in patients receiving 15 mg Folic Acid (Formula CP) daily for 1 month. Other side effects reported in patients receiving 15 mg daily include altered sleep patterns, difficulty in concentrating, irritability, overactivity, excitement, mental depression, confusion, and impaired judgment. Decreased vitamin B12 serum levels may occur in patients receiving prolonged Folic Acid (Formula CP) therapy.

In an uncontrolled study, orally administered Folic Acid (Formula CP) was reported to increase the incidence of seizures in some epileptic patients receiving phenobarbital, primidone, or diphenylhydantoin. Another investigator reported decreased diphenylhydantoin serum levels in folate-deficient patients receiving diphenylhydantoin who were treated with 5 mg or 15 mg of Folic Acid (Formula CP) daily.

CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 OR LEADING PHARMA, LLC AT 844-740-7500.

See also:
What are the possible side effects of Magnesium (Formula CP)?

The adverse effects of parenterally administered Magnesium (Formula CP) usually are the result of Magnesium (Formula CP) intoxication. These include flushing, sweating, hypotension, depressed reflexes, flaccid paralysis, hypothermia, circulatory collapse, cardiac and central nervous system depression proceeding to respiratory paralysis. Hypocalcemia with signs of tetany secondary to Magnesium (Formula CP) sulfate therapy for eclampsia has been reported.

See also:
What are the possible side effects of Potassium (Formula CP)?

Applies to Potassium (Formula CP) citrate: oral patch extended release, oral solution, oral tablet, oral tablet extended release

As well as its needed effects, Potassium (Formula CP) citrate may cause unwanted side effects that require medical attention.

Major Side Effects

If any of the following side effects occur while taking Potassium (Formula CP) citrate, check with your doctor immediately:

Incidence not known:

• Abdominal or stomach discomfort
• diarrhea
• nausea
• vomiting

If any of the following symptoms of overdose occur while taking Potassium (Formula CP) citrate, get emergency help immediately:

Symptoms of overdose:

• Abdominal or stomach pain
• confusion
• difficult breathing
• irregular heartbeat
• nervousness
• numbness or tingling in the hands, feet, or lips
• shortness of breath
• weakness or heaviness of the legs

See also:
What are the possible side effects of Selenium (Formula CP)?

Applies to Selenium (Formula CP) sulfide topical: topical cream, topical foam, topical lotion, topical shampoo, topical suspension

As well as its needed effects, Selenium (Formula CP) sulfide topical may cause unwanted side effects that require medical attention.

Severity: Moderate

If any of the following side effects occur while taking Selenium (Formula CP) sulfide topical, check with your doctor or nurse as soon as possible:

Less common or rare:

• Skin irritation

Minor Side Effects

Some Selenium (Formula CP) sulfide topical side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

More common:

• Unusual dryness or oiliness of hair or scalp

• Increase in normal hair loss

See also:
What are the possible side effects of Ubidecarenone (Formula CP)?

This product usually has very few side effects. Nausea, loss of appetite, upset stomach, or diarrhea may rarely occur. If any of these effects persist or worsen, contact your doctor promptly.

A very serious allergic reaction to this product is rare. However, seek immediate medical attention if you notice any of the following symptoms of a serious allergic reaction: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

See also:
What are the possible side effects of Vitamin B12 (Formula CP)?

Applies to cyanocobalamin: intramuscular solution

Other dosage forms:

• nasal gel/jelly, nasal spray

As well as its needed effects, cyanocobalamin (the active ingredient contained in Vitamin B12 (Formula CP)) may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking cyanocobalamin, check with your doctor or nurse immediately:

Incidence not known:

• Abdominal or stomach pain
• bleeding from the gums or nose
• blue lips and fingernails
• chest pain
• cough
• coughing that sometimes produces a pink frothy sputum
• decreased urine output
• difficult, fast, noisy breathing, sometimes with wheezing
• difficulty with swallowing
• dilated neck veins
• dizziness
• extreme fatigue
• eye pain
• fast heartbeat
• headache
• hives, itching, or skin rash
• increased sweating
• irregular breathing
• irregular heartbeat
• pale skin
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• ringing in the ears
• swelling of the face, fingers, feet, or lower legs
• tightness in the chest
• unusual tiredness or weakness
• weight gain

Minor Side Effects

Some cyanocobalamin side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Incidence not known:

• Diarrhea
• skin rash with a general disease

Allergic sensitization has been reported rarely following oral and parenteral administration of Vitamin B3 (Formula CP).

At recommended doses, nicotinamide is expected to be well tolerated. Gastrointestinal distress such as nausea or vomiting have been associated with the administration of nicotinamide or zinc at doses greater than the recommended dose of nicotinamide

Nicotinamide: Dizziness, headache, hyperglycemia, nausea, vomiting, diarrhea, elevations in liver function tests, hepatotoxicity, blurred vision, flushing, rash.

See also:
What are the possible side effects of Vitamin C (Formula CP)?

Applies to ascorbic acid: oral capsule, oral capsule extended release, oral capsule liquid filled, oral granule, oral liquid, oral lozenge/troche, oral powder, oral powder for solution, oral powder for suspension, oral solution, oral syrup, oral tablet, oral tablet chewable, oral tablet extended release, oral wafer

As well as its needed effects, ascorbic acid (the active ingredient contained in Vitamin C (Formula CP)) may cause unwanted side effects that require medical attention.

Severity: Moderate

If any of the following side effects occur while taking ascorbic acid, check with your doctor or nurse as soon as possible:

Less common or rare: - with high doses

• Side or lower back pain

Minor Side Effects

Some ascorbic acid side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Less common or rare: - with high doses

• Diarrhea
• dizziness or faintness (with the injection only)
• flushing or redness of skin
• headache
• increase in urination (mild)
• nausea or vomiting
• stomach cramps

See also:
What are the possible side effects of Vitamin E (Formula CP)?

Applies to Vitamin E (Formula CP): oral capsule, oral capsule liquid filled, oral liquid, oral powder for solution, oral solution, oral tablet, oral tablet chewable

In addition to its needed effects, some unwanted effects may be caused by Vitamin E (Formula CP) (the active ingredient contained in Centrum Singles-Vitamin E (Formula CP)). In the event that any of these side effects do occur, they may require medical attention.

Severity: Moderate

If any of the following side effects occur while taking Vitamin E (Formula CP), check with your doctor or nurse as soon as possible:

With doses greater than 400 Units a day and long-term use

• Blurred vision
• diarrhea
• dizziness
• headache
• nausea or stomach cramps
• unusual tiredness or weakness

See also:
What are the possible side effects of Zinc (Formula CP)?

Applies to Zinc (Formula CP) sulfate: capsules, tablets

Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Nausea; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur while taking Zinc (Formula CP) sulfate (the active ingredient contained in Zinc (Formula CP))

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe vomiting; unusual restlessness; very dry mouth, eyes, or skin.